Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. - Wikidata - awgldk - TriplyDB

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

http://www.wikidata.org/entity/Q34695419

about

Kidney disease: new technologies translate mechanisms to cure Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art New susceptibility loci associated with kidney disease in type 1 diabetes.Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.Effects of glucose and blood pressure control on diabetic kidney disease in old patients with type 2 diabetes Renal outcomes in patients with type 1 diabetes and macroalbuminuria Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.Risk for ESRD in type 1 diabetes remains high despite renoprotection.Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study A tutorial on sensitivity analyses in clinical trials: the what, why, when and how.Risk factors for cerebrovascular disease mortality among the elderly in Beijing: a competing risk analysis.Predicting mortality in patients with diabetes starting dialysis.Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).Incidence of end stage renal disease among type 1 diabetes: a nationwide cohort study in Taiwan.The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients Vascular disease, ESRD, and death: interpreting competing risk analyses.High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey.Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.Prediction of the 20-year incidence of diabetes in older Chinese: Application of the competing risk method in a longitudinal study.Risk for end-stage renal disease over 25 years in the population-based WESDR cohort.Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease.The timing of dialysis and kidney transplantation in type 1 diabetes.Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.The Gomez' equations and renal hemodynamic function in kidney disease research.Fracture risk and mortality post-kidney transplantation.Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes.Diabetic kidney disease.Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study.Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.

P2860

Q26825227-10426F8A-5580-4FF4-9ABF-BA70830197B3 Q26827335-6826717B-C10B-4473-A224-859F5FE97A71 Q29417066-EF518D91-626E-4F4D-9678-2663DECDB90B Q30238531-6D91BADE-A213-41F3-9049-9CD3BBAAC9E3 Q34012168-71752914-E28D-48ED-8EFE-36516BD7B799 Q34260068-00E6115E-090A-4C21-BD42-48D54DB27357 Q34568748-94497AD6-921C-41B5-B791-2094791775C0 Q34695426-FB2DE308-D7A2-48BD-ABE2-97629FBB570F Q34774837-98D24CA6-6C5C-4A4C-BEFE-47A4B9D149A0 Q34819923-40EF8AC6-1377-4C64-A157-4B5779525F45 Q35087884-0246F4F4-19F0-4759-9902-3753B5605F2F Q35110764-0993921A-7FAC-4B87-818C-C6C5F08393C2 Q35957661-80ECA91D-C663-43E4-886E-762ED3D69B9A Q36154168-B03FC060-A3BA-44A8-B6C1-79A86BE454DE Q36183114-A014AD3C-2F70-47E2-93CC-8AB3AEEB5A57 Q36194944-9C3A1CDB-F51C-407A-8628-EBA1A13B1FF2 Q36294356-2D631CB7-AB1F-459B-BCA9-3E3FB857B72F Q36328889-C7A93488-121F-4054-AB51-1F680B9467A0 Q36334563-0A98FBD9-99BD-4F3F-BA18-D698D3FC7888 Q36666443-D2ACFB73-8FDB-4CDD-9494-996721CAC19A Q36818854-13F45350-5679-478C-B51B-451E07C1F781 Q36844894-54E7FEBC-1DE8-4061-8DB1-53CA1118E006 Q36942114-22D81982-ACFE-43EB-9685-45D418DEFA63 Q37328907-A96C3F4A-0376-401E-B341-6F856FE33E1A Q37504054-81425BE6-BD81-437C-94E0-4D1C46122DD1 Q37521459-AEB87153-F6E4-4F10-8BE1-F92C80B731E2 Q37685792-C41B5A41-CC81-46DE-A8A9-4E4BF8A91CD9 Q37975222-C164DBE3-DCBA-4D27-ADD3-B373752D5DD8 Q38018816-44550921-8B63-4FC7-92C0-EE51684BA601 Q38105277-51D53FB4-20A0-49C5-B35E-C638BD081EE6 Q38629322-7A84992E-2E18-4DE7-AFCE-5A216556D06B Q38732291-16D83154-2B8D-44E0-A8CE-04DC9823A23E Q38949048-87AC0B3A-AB47-4DC5-BFB4-DB0F87E21D87 Q38970121-66A6E44F-5E49-4301-91E5-CAAACD1B790E Q41198632-69B3853F-52D6-42AF-BE46-7439DF9BC617 Q43721013-5851EC0D-241C-495B-804D-F02FD7F7587E Q46009536-F8C6FE33-E77E-4E8E-8373-205693809BC5 Q47634844-FCAA6BBD-EB15-4072-AE44-0CD3ABC2FBF1 Q47959306-AB2650D0-2224-4167-8DE2-5B8D714BAF89 Q48176321-27F57D78-6788-4878-B8BF-AC81482C1E65

P2860

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

http://www.wikidata.org/entity/Q34695419

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@ast

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@en

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@nl

type

label

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@ast

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@en

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@nl

prefLabel

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@ast

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@en

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@nl

P1433

Q34695419-BACF8195-BF1B-4411-BBA2-DBA351131D1F

P1476

Q34695419-F50AB82F-0A28-42EA-BBD4-401E64F9BCFD

P2093

Q34695419-00C31198-DF14-49AC-9E4F-ABD11EF39E1C

Q34695419-05AA22A6-A8DC-49EE-B044-1303FD1EF1F0

Q34695419-33F3AF04-14BF-4A4D-9C4D-402C503D577E

Q34695419-490A93C6-4E9A-419C-9019-3947BA4707B8

Q34695419-5B2668B3-5285-440F-BE41-FBBD410FC8BE

Q34695419-8F847CED-995C-4B9A-8646-8B4A1FD0FBFF

P2860

Q34695419-04546580-99AC-44C1-82D4-B0463AF9832B

Q34695419-084F3AEF-58B0-4C9F-90C9-9B255AC9821D

Q34695419-114DD000-1A45-464B-A35F-BB6C48DC5FE5

Q34695419-16E47B42-ED0F-4FC0-AA9F-A0C04EF2C209

Q34695419-1D42D51D-67B2-4824-AFD8-4EDDBB9B838B

Q34695419-22774F0E-F3DD-49E9-98EA-8EB6AA39D14C

Q34695419-340981C7-707D-4DD2-8BB4-2041556BB65A

Q34695419-373B1182-F49F-4A2C-93FC-1AD6048BB8BC

Q34695419-3FC50C80-B2A7-4F52-91AF-531A7040664E

Q34695419-48845072-087E-4305-896D-3BA91958EAAB

P304

Q34695419-8935EE4B-6F8E-4138-BD66-0333B7EBDF45

P31

Q34695419-9BE64D69-962E-4C9B-9B65-23ADF7A84187

P356

Q34695419-C2EE6DAA-7368-4374-A8E8-FE3E589BE04E

P433

Q34695419-E166F10F-1119-4CDD-8B3F-926A36472D17

P478

Q34695419-20614F5F-9E37-460A-B820-A1C850E810FE

P50

Q34695419-070D0F8D-6CD3-443B-8FC8-025CAB1F497F

Q34695419-1006F523-8BC7-42DE-B2E2-550C0C3DF0B9

Q34695419-7D347DF8-AC97-4DDE-931C-F0CE5E74E9DE

Q34695419-A7F62A3C-26B2-4E3D-B4B6-3917F4477538

Q34695419-B2D8FD56-5F3C-4BD0-8A05-61542BBF6A1F

P577

Q34695419-AB64D9DE-CB05-4C5E-B081-E07AA041AF51

P698

Q34695419-838C765A-EA6B-4C82-8A78-19B53A6D4295

P921

Q34695419-881531E3-5C89-4516-9E21-392B5371D9B6

Q34695419-BE298B94-F594-401B-A1D7-AAAA29DC724D

P932

Q34695419-BC6BD9CF-1129-427C-948A-A8BE0ABEC4C5

P356

P1433

Journal of the American Society of Nephrology

P1476

Competing-risk analysis of ESR ...... diabetes and macroalbuminuria.

@en

P2093

Daniel Gordin

http://www.w3.org/2001/XMLSchema#string

Johan Wadén

http://www.w3.org/2001/XMLSchema#string

John L Moran

http://www.w3.org/2001/XMLSchema#string

Markku Saraheimo

http://www.w3.org/2001/XMLSchema#string

Nina Tolonen

http://www.w3.org/2001/XMLSchema#string

Valma Harjutsalo

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.

A note on including time-dependent covariate in regression model for competing risks data.

Analysing and interpreting competing risk data.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies.

P304

537-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010020194

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Per-Henrik Groop

FinnDiane Study Group

P577

2011-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21335512

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3060447

http://www.w3.org/2001/XMLSchema#string